KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Neogenomics (NEO) Leases (2016 - 2025)

Neogenomics' Leases history spans 15 years, with the latest figure at $78.4 million for Q4 2025.

  • For Q4 2025, Leases fell 1.43% year-over-year to $78.4 million; the TTM value through Dec 2025 reached $78.4 million, down 1.43%, while the annual FY2025 figure was $78.4 million, 1.43% down from the prior year.
  • Leases reached $78.4 million in Q4 2025 per NEO's latest filing, down from $80.1 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $102.3 million in Q3 2021 to a low of $50.9 million in Q1 2021.
  • Average Leases over 5 years is $86.1 million, with a median of $86.9 million recorded in 2023.
  • Peak YoY movement for Leases: soared 123.21% in 2021, then dropped 13.28% in 2024.
  • A 5-year view of Leases shows it stood at $102.2 million in 2021, then dropped by 5.96% to $96.1 million in 2022, then dropped by 4.52% to $91.8 million in 2023, then decreased by 13.28% to $79.6 million in 2024, then fell by 1.43% to $78.4 million in 2025.
  • Per Business Quant, the three most recent readings for NEO's Leases are $78.4 million (Q4 2025), $80.1 million (Q3 2025), and $82.9 million (Q2 2025).